Neoadjuvant therapy and organ preservation in rectal cancer

TCOL Session 5: Rectal Cancer Response to Neoadjuvant Treatment: Does Tumor Size Influence Response?Подробнее

Adjuvant chemotherapy for patients with rectal cancerПодробнее

Doctors in Shanghai boost chances of organ preservation for rectal cancer patientsПодробнее

Neo-adjuvant therapy in Rectum part 1Подробнее

S2 Episode 4: The Evolution of Nonoperative Rectal Cancer ManagementПодробнее

Evaluating organ preservation in node-negative low rectal cancerПодробнее

S1 Episode 3: Treating Rectal Cancer: PROSPECT, PRODIGE, or OPRA?Подробнее

2nd Oncology Beyond the Obvious (OBTO) In-Person Conference | Rectal CancerПодробнее

NESS Intellectual Happy Hour Journal Club - Thursday, December 14th, 2023, Dr. Tess AuletПодробнее

Locally Advanced Rectal Cancer TreatmentПодробнее

Locally advanced rectal cancer & total neoadjuvant therapy - Induction vs consolidation chemotherapyПодробнее

Rectal Cancer | Neo-adjuvant therapy | Neo-adjuvant chemo-radiotherapy | Total Neo-adjuvant therapyПодробнее

Updates Rectal Cancer | 2023 Best of GI Cancer ConferenceПодробнее

Is short-course radiation the best course of therapy in rectal cancer?Подробнее

Organ preservation for rectal cancer: long-course chemoradiation vs short-course radiation therapyПодробнее

Challenges associated with organ preservation in patients with rectal cancerПодробнее

NBE- DEBATE: CLINICAL CR POST NEOADJUVANT TREATMENT IN RECTAL CANCERS- WATCH & WAIT YES/NOПодробнее

Organ Preserving Therapy of Advanced Rectal Cancer (OPRA Study)Подробнее

RECTAL CANCER: TOTAL NEOADJUVANT TREATMENTПодробнее